1)Kagan KO, et al : Relation between increased fetal nuchal translucency thickness and chromosomel detect. Obstet Gynecol 107 : 6-10, 2006
2)Cicero S, et al : Absent nasal bone at 11-14 weeks of gestaion and chromosomal defects. Ultrasound Obstet Gynecol 22 : 31-35, 2003
3)Maiz N, et al : Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 33 : 512-517, 2009
4)Kagan KO, et al : Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 33 : 18-22, 2009
5)Nicolaides KH : Screening for fetal aneuploidies at 11 to 13 weeks. Prenatal Diagnosis 31 : 7-15, 2011
6)Maiz N, et al : Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation. Obstet Gynecol 112 : 598-605, 2008
7)Pereira S, et al : Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol 117 : 1384-1391, 2011
8)Scala C, et al : Fetal tricuspid regurgitation in the first trimester as a screening maker for congenital heart defects : systematic review and meta-analysis. Fetal Diagn Ther 42 : 1-8,2017
9)Lund IC, et al : Chromosomal microarray in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 45 : 95-100, 2015
10)Maya I, et al : Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstet Gynecol 50 : 332-335,2017
11)Egloff M, et al : Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency : a French multicenter study. Ultrasound Obstet Gynecol 52 : 715-721, 2018